The "Global Immunoprotein Diagnostic Testing Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
The immunoprotein diagnostic testing market is poised to grow by $ 5.56 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period.
This study identifies the growing focus on next-generation products as one of the prime reasons driving the immunoprotein diagnostic testing market growth during the next few years. Also, the increasing use of cloud-based solutions and the emergence of a nanoparticle-based immunoassay for protein test will lead to sizable demand in the market.
The market is driven by the increasing prevalence of infectious diseases, increasing use of immunochromatography-based cassette kits or test strips, and focus on advanced products.
The reports on immunoprotein diagnostic testing market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The immunoprotein diagnostic testing market analysis includes end-user segment and geographical landscapes.
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunoprotein diagnostic testing market vendors that include Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., DiaSorin Group, F. Hoffmann-La Roche Ltd., Merck KGaA, Siemens Healthineers AG, The Carlyle Group Inc., and Thermo Fisher Scientific Inc.
Also, the immunoprotein diagnostic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Key Topics Covered:
Value chain analysis
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market Segmentation by Application
Comparison by Application
Infectious disease testing - Market size and forecast 2019-2024
Oncology and endocrinology testing - Market size and forecast 2019-2024
Autoimmune testing - Market size and forecast 2019-2024
Allergy testing - Market size and forecast 2019-2024
Market opportunity by Application
Market Segmentation by End-user
Comparison by End user
Hospitals and clinics - Market size and forecast 2019-2024
Diagnostic laboratories - Market size and forecast 2019-2024
Market opportunity by End user
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Volume drivers - Demand led growth
Market positioning of vendors
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche Ltd.
Siemens Healthineers AG
The Carlyle Group Inc.
Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/jiv38k
View source version on businesswire.com: https://www.businesswire.com/news/home/20201202005616/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900